Implanted Conductive Member for Selective Nerve Stimulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current nerve stimulation technologies face challenges in achieving selective activation of specific nerve branches with minimal activation of non-targeted tissue, leading to reduced therapeutic efficacy and increased side effects due to invasive procedures and limited precision.
Innovation Solution
A transcutaneous tissue stimulation system with an external electrical generator and an implanted conductive member positioned near the target nerve tissue, using paired configurations of external stimulation elements and subcutaneously implanted passive elements to modulate electrical fields and reduce stimulation spillover, allowing for selective nerve stimulation with lower amplitude and shorter pulse width.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If transcutaneous electrical stimulation is used to provide non-invasive nerve stimulation, then ease of operation and patient comfort are improved, but selective nerve activation is not readily achieved and stimulation spillover to non-targeted tissue occurs
Solution Approach 1:
The patent introduces an implanted conductive member as an intermediary between the external electrical generator and the target nerve tissue. This mediator focuses the electrical field precisely at the target nerve while minimizing spread to surrounding tissues, thereby achieving selective activation without invasive surgery. The conductive member acts as a field-shaping intermediary that bridges the gap between non-invasive application and precise targeting.
2Manufacturing precision
If implanted neurostimulation systems with multiple components are used to achieve selective nerve activation, then stimulation selectivity is improved, but device complexity and surgical risk are increased
Solution Approach 1:
The patent extracts the pulse generator component from the implanted system, placing it externally instead of internally. This leaves only a simple passive conductive member implanted in the body, which can be as simple as a conductive gel or paste applied to the skin. The complex active components remain outside the body, dramatically reducing implant complexity and surgical risk while maintaining selective stimulation capability through the conductive member's field-focusing property.
3Reliability
If high amplitude and long pulse width stimulation is used to ensure nerve activation, then therapeutic efficacy is improved, but activation of non-targeted tissue and side effects increase
Solution Approach 1:
The patent applies local quality by concentrating the electrical field energy precisely at the target nerve location using the implanted conductive member. This creates a localized high-intensity field at the target while keeping surrounding areas at low intensity. The conductive member's geometry and placement are optimized to create this non-uniform field distribution, ensuring strong activation of the target nerve with minimal spillover to adjacent tissues, thereby achieving reliable therapy with reduced side effects.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system enhances neural excitability of targeted nerves while minimizing activation of non-targeted tissues, improving therapeutic efficacy, comfort, and reducing side effects, and is applicable for various conditions such as overactive bladder, chronic pain, and migraines.
Implementation Method 1
using paired configurations of external stimulation elements and subcutaneously implanted passive elements to modulate electrical fields
Data Source
AI summary
Methods and systems for improving nerve stimulation are disclosed which relate to shaping characteristics of the stimulation field such as by using different geometries and locations of stimulation. In embodiments, systems and methods are provided to improve selective modulation of specific targeted neural substrate, while minimizing the activation of adjacent non-targeted nervous tissue. While aspects of the disclosed technologies can be applied to any part of the central and peripheral nervous systems for treatment various disorders and providing symptom relief to provide for therapy related to pelvic floor disorders such as overactive bladder


